Emerging evidence supports the argument that psoriatic arthritis arises from two pathways and that affected immune cells may ...

Patients with rheumatoid arthritis who demonstrate consistent long-term elevation of inflammatory markers have an increased ...

A study of biologic-naive patients with psoriasis or PsA found that IL-17, IL-12/23, and IL-23 inhibitors have comparable cardiovascular and thrombotic risk profiles as TNF inhibitors.